TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

• Status: Unknown status
• Trial end date: 2018-04-01

Summary

It is a prospective and multi-center clinical research in China to compare the efficacy, safety and related impact factors between TACE alone and TACE combined with synchronous multi-point MWA/RFA for large and huge liver cancer.

• Phase: Phase 3

Details

• Lead Sponsor: Shanghai Zhongshan Hospital
• Collaborators: Anhui Provincial Hospital; Changhai Hospital; Chinese PLA General Hospital; Dalian University affiliated Zhongshan Hospital; Eastern Hepatobiliary Surgery Hospital; First Affiliated Hospital of Xinjiang Medical University; Guangdong General Hospital; Guangdong Provincial People's Hospital; Henan Cancer Hospital; Hunan Provincial People's Hospital; Jiangsu Cancer Institute & Hospital; Jilin Provincial Tumor Hospital; LanZhou University; Nanfang Hospital of Southern Medical University; Qilu Hospital; Qilu Hospital of Shandong University; Shandong Tumor Hospital; Shanghai Cancer Hospital, China; Shengjing Hospital; Sichuan Cancer Hospital and Research Institute; Sun Yat-sen University; The Affiliated Zhongshan Hospital of Dalian University; The First Affiliated Hospital of Anhui Medical University; The First Hospital of Lanzhou University; The Third Affiliated Hospital of Harbin Medical University; Wuhan Union Hospital, China; Xijing Hospital; Zhejiang Cancer Hospital
• Treatments: Epirubicin; Ethiodized Oil